These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2892773)

  • 41. Neuroleptic-induced pseudo-catatonia.
    Dose M
    Pharmacopsychiatry; 2001 Nov; 34(6):262-4. PubMed ID: 11778149
    [No Abstract]   [Full Text] [Related]  

  • 42. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 43. [Lethal catatonia and its differential diagnosis with the neuroleptic malignant syndrome].
    Andreu Giménez L; Robert Gates J; Jover Díaz F; Pagán Acosta G; Merino Sánchez J
    Rev Neurol; 2002 Feb 16-28; 34(4):399-400. PubMed ID: 12022063
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroleptic malignant syndrome and lethal catatonia.
    Munoz RA
    Am J Psychiatry; 1987 Oct; 144(10):1369-70. PubMed ID: 2889379
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroleptic malignant syndrome.
    Scarlett JD; Zimmerman R; Berkovic SF
    Aust N Z J Med; 1983 Feb; 13(1):70-3. PubMed ID: 6136267
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome?
    Kontaxakis VP; Vaidakis NM; Christodoulou GN; Valergaki HC
    Neuropsychobiology; 1990; 23(1):38-40. PubMed ID: 2280828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
    Mann SC; Auriacombe M; Macfadden W; Caroff SN; Cabrina Campbell E; Tignol J
    Encephale; 2001; 27(3):213-6. PubMed ID: 11488250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suspected neuroleptic catatonia induced by clozapine.
    Biancosino B; Zanchi P; Agostini M; Grassi L
    Can J Psychiatry; 2001 Jun; 46(5):458. PubMed ID: 11441795
    [No Abstract]   [Full Text] [Related]  

  • 49. [Catatonia and neuroleptic malignant syndrome in a mentally retarded patient].
    Heikkilä J; Raitasuo S; Lauerma H; Mölsä P
    Duodecim; 1992; 108(12):1120-4. PubMed ID: 1366062
    [No Abstract]   [Full Text] [Related]  

  • 50. Occurrence of neuroleptic malignant syndrome in a narcoleptic patient.
    Chayasirisobhon S; Cullis P; Veeramasuneni RR
    Hosp Community Psychiatry; 1983 Jun; 34(6):548-50. PubMed ID: 6134661
    [No Abstract]   [Full Text] [Related]  

  • 51. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neuroleptic malignant syndrome. Efficacy of bromocriptine].
    Azorin JM; Bouchacourt M; Lavergne T; Giudicelli S
    Presse Med; 1984 Jun; 13(27):1702. PubMed ID: 6146134
    [No Abstract]   [Full Text] [Related]  

  • 53. [Catatonia and neuroleptic malignant syndrome in view of a psychopathological and pathophysiological overlap: a brief review].
    Asztalos Z; Egervári L; Andrássy G; Faludi G; Frecska E
    Neuropsychopharmacol Hung; 2014 Mar; 16(1):19-28. PubMed ID: 24687015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome.
    Wilson MP; Vilke GM; Hayden SR; Nordstrom K
    J Emerg Med; 2016 Jul; 51(1):66-9. PubMed ID: 27247083
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study.
    Berardi D; Amore M; Keck PE; Troia M; Dell'Atti M
    Biol Psychiatry; 1998 Oct; 44(8):748-54. PubMed ID: 9798079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic rounds: neuroleptic malignant syndrome.
    Schulz P; Dick P
    Clin Ther; 1986; 8(6):605-6, 722-3. PubMed ID: 2878725
    [No Abstract]   [Full Text] [Related]  

  • 58. [Neuroleptic malignant syndrome. Reappraisal apropos of 2 cases].
    Bourgeois M; Tignol J; Villeger M; Henry P; Daubech JF; Laforge E; Durand J
    Ann Med Psychol (Paris); 1981 May; 139(5):547-56. PubMed ID: 6118087
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroleptic malignant syndrome.
    Longhurst JG
    Br J Psychiatry; 1995 Apr; 166(4):537-8. PubMed ID: 7795930
    [No Abstract]   [Full Text] [Related]  

  • 60. Catatonia and the neuroleptic malignant syndrome--a single entity?
    White DA
    Br J Psychiatry; 1992 Oct; 161():558-60. PubMed ID: 1393347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.